2021 annual financial data
Dermata Therapeutics 2021 Operating cash flow margin
Direct answer
Operating cash flow margin was Not calculable.
Operating income was -7,856,864 USD and net income was -7,948,090 USD.
Operating cash flow was -5,693,392 USD.
Get free Dermata Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -7,856,864 USD
- Net income
- -7,948,090 USD
- Operating cash flow
- -5,693,392 USD